Georgetown University

One of the largest repositories of molecular brain cancer data in the world, the enhanced REMBRANDT is more comprehensive than an earlier NCI-hosted version.

The researchers found that tumors expressing STAG2 as a biomarker are twice as likely to recur and progress toward muscle invasion and metastasis.

Considering the widespread use of the cell line, these findings could have significant implications for the research community. 

Biocept hopes data from the study will support the clinical utility of its liquid biopsy test to detect drug resistance mutations in NSCLC.

Researchers from EBI, Georgetown, and others are mapping protein annotations to the human reference genome to it more easily accessible.

The partners have jointly developed a research agenda including immune-therapy and NGS with the goal of creating an NCI-recognized oncology consortium.

The Caris Centers of Excellence for Precision Medicine Network will establish tumor profiling standards and provide access to Caris' database of patient outcomes.

The deal opens the door for Amarantus to license as many as six patents to help diagnose patients at risk of developing Alzheimer's disease. 

WASHINGTON, DC (GenomeWeb) – At a conference held here this week to address health disparities in genomic medicine, researchers presented their findings on how minorities viewed the use of genomic tests and whether their knowledge about receiving such testing during the course of cancer treatment

NEW YORK (GenomeWeb News) – While variants in the gene FTO have previously been associated with a propensity toward obesity, the University of Chicago's Marcelo Nóbrega and colleagues reported in Nature this week that those obesity-linked variants in FTO actually

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.